FeesSafety
Pluang+

Eastman Chemical rated 'Buy' with strong earnings growth and 5.4%+ dividend yield despite market pessimism.

Analyst Insights
14 Oct 2026, 08:03 WIB
Seeking Alpha
View Source
Bullish
Eastman Chemical rated 'Buy' with strong earnings growth and 5.4%+ dividend yield despite market pessimism.

Eastman Chemical Company (EMN) is reaffirmed as a 'Buy' with a fair value of $104 per share and a price target of $84 per share. The company showed operational improvements with a 23% increase in adjusted earnings per share (AEPS) and a 16% rise in EBIT in Q2 2026, contrasting with the market's pessimistic view reflected in a low 7-8x price-to-earnings multiple. The investment case is supported by cost savings, volume recovery, and advances in molecular recycling, projecting a normalized EPS potential of $8 per share. Additionally, EMN offers a dividend yield above 5.4%, maintains a strong balance sheet, and demonstrates resilience relative to its sector, making its current valuation attractive for investors.

Eastman Chemical's recent market outlook is provided here as context. For readers following Basic Materials-sector stocks, 62 US stocks were priced on Pluang with 30 rising and 32 falling. Notable movers include SSRM at USD 33.25 down 6.18%, IFF at USD 88.10 up 3.70%, and EXK at USD 8.24 down 3.51%. This data is as of Oct 14, 2026 11:21 WIB.

More News

Fed Chair Warsh must engage Congress more or risk losing support and his reforms failing.

Fed Chair Warsh must engage Congress more or risk losing support and his reforms failing.

Federal Reserve Chair Kevin Warsh is making significant changes, including reducing market guidance to encourage more real-time price setting. However, JPMorgan Chase warns that without better engagement with Congress, Warsh risks serving only one te...

Market News
Neutral
1 hour ago
La-Z-Boy sales rise 4%, expands company-owned stores, returns $32M to shareholders in Q2 2027

La-Z-Boy sales rise 4%, expands company-owned stores, returns $32M to shareholders in Q2 2027

In Q2 fiscal 2027, La-Z-Boy reported a 4% increase in consolidated sales excluding divestitures, driven by expanding company-owned stores now 62% of its network and consolidating U.S. manufacturing to reduce tariff risks. The company returned $32 mil...

Company Fundamentals
Bullish
1 hour ago
SpaceX's upcoming share unlock may pressure stock, following mixed October price reactions.

SpaceX's upcoming share unlock may pressure stock, following mixed October price reactions.

SpaceX went public with less than 5% of its shares available for trading, limiting initial selling pressure but raising concerns about future share unlocks. In October, several unlock events increased the public float, causing mixed stock reactions i...

Market News
Bearish
2 hours ago
e.l.f. Beauty outpaces On with faster growth despite On's premium brand strength and lower valuation.

e.l.f. Beauty outpaces On with faster growth despite On's premium brand strength and lower valuation.

e.l.f. Beauty and On are both strong consumer brands, with e.l.f. focusing on affordable vegan cosmetics and On on premium athletic footwear. e.l.f. Beauty grew revenue by about 40% to $1.9 billion and posted $87 million net income, leveraging major ...

Market News
Bullish
2 hours ago
Anthropic plans IPO to fund AI-driven bioscience, with potential future ties to Ginkgo Bioworks' lab automation.

Anthropic plans IPO to fund AI-driven bioscience, with potential future ties to Ginkgo Bioworks' lab automation.

Anthropic is set to go public on November 19, raising tens of billions to boost its AI capabilities in bioscience, focusing on lab automation and robotics. Ginkgo Bioworks, a leader in automated biotech labs, collaborates with OpenAI but has no curre...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App